AAOI
Applied Optoelectronics, Inc.
AAOI has the edge over IMMR overall, supported by stronger valuation and stronger modeled upside.
IMMR
Immersion Corporation
IMMR has lower modeled downside risk, despite its lower overall score.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
IMMR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
IMMR's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
IMMR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.8x | $0.95 | -86% |
| Fair | 7.4x | $2.51 | -64% |
| Expensive | 20x | $6.92 | -0.7% |
| Current | 21x | $6.97 | — |
Historical ranges are pointers, not guarantees.
IMMR's PE is in its expensive range at 21x.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
IMMR Forward outlook
There aren't enough analyst estimates for IMMR to show an outlook.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
IMMR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | -51% |
| Q1 2024 | $1.38 | +35% |
| Q4 2023 | $1.04 | +13% |
| Q3 2023 | $1.13 | +214% |
| Q2 2023 | $1.28 | +412% |
| Q1 2023 | $1.02 | +117% |
| Q4 2022 | $0.92 | +136% |
| Q3 2022 | $0.36 | -43% |
IMMR has the edge over AAOI on earnings quality, reporting a profit while its opponent remains loss making.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI's revenue has grown year over year for 10 quarters in a row: $270M last quarter, up 127% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI has the edge over IMMR on profitability, with a higher operating margin.
IMMR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $294.4M | +0.8% |
| Q2 2026 | $270M | -5.2% |
| Q1 2026 | $518.5M | +9.2% |
| Q4 2025 | $650.2M | +5.5% |
| Q3 2025 | $292M | +194% |
| Q2 2025 | $284.9M | +522% |
| Q1 2025 | $474.8M | +4474% |
| Q4 2024 | $616.2M | +6399% |
IMMR's revenue has held roughly level: $294M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -6.8% | +2.2 points |
| Q2 2026 | 2.7% | +3.1 points |
| Q1 2026 | 1% | -4.6 points |
| Q4 2025 | 6.2% | -4.3 points |
| Q3 2025 | -9% | -35 points |
| Q2 2025 | -0.4% | -35 points |
| Q1 2025 | 5.5% | -32 points |
| Q4 2024 | 10% | -38 points |
IMMR's operating margin was −6.8% last quarter, up 2.2 points from the same quarter a year ago.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
IMMR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.1M | +$18.3M |
| Q2 2026 | $79.4M | +69% |
| Q1 2026 | -$37.5M | +$8.8M |
| Q2 2025 | $47M | +49% |
| Q1 2025 | -$46.2M | -691% |
| Q2 2024 | $31.6M | +797% |
| Q1 2024 | $29.9M | +749% |
| Q4 2023 | $7.8M | -3% |
IMMR has the edge over AAOI on cash generation, producing positive trailing cash flow while its opponent burns cash.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IMMR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q1 2024 | -2.9x | Net Cash |
| Q4 2023 | -3.1x | Net Cash |
| Q3 2023 | -1.5x | Net Cash |
| Q2 2022 | -3.2x | Net Cash |
IMMR has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
IMMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 26.0 | Neutral |
IMMR's weekly RSI is 49 (neutral) and its Stochastic is 26 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
IMMR PE vs Technology Sector
| Metric | IMMR | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 84 | 35 | 49 pts above |
IMMR is trading at 21x earnings, a 26% discount to the Technology sector's median of 28x.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has fallen below most of its moving averages, though it's still 43% above its 200-week average.
IMMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.14 | 2.4% below |
| 20 week MA | $7.20 | 3.2% below |
| 50 week MA | $6.70 | 4% above |
| 100 week MA | $7.11 | 2% below |
| 200 week MA | $7.51 | 7.2% below |
IMMR's trend is mixed: it's above one of its five weekly moving averages, and 7.2% below its 200-week average.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over IMMR on returns for 2026, with the stronger performance.
IMMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.58 | $8.93 | +18% |
| 2021 | $8.93 | $6.10 | -32% |
| 2022 | $6.10 | $7.33 | +20% |
| 2023 | $7.33 | $7.06 | -3.7% |
| 2024 | $7.06 | $9.00 | +27% |
| 2025 | $9.00 | $6.85 | -24% |
| 2026 YTD | $6.85 | $6.97 | +1.8% |
IMMR has finished lower in three of the last six years. It's up 1.8% so far in 2026.